The use of antivascular endothelial growth factor agents in the perioperative period in diabetic vitrectomy

Middle East African Journal of Ophthalmology

Volumn 19, Issue 1, 2012, Pages 83-87

  Abu Yaghi, Nakhleh E ^a   Bakri, Sophie J ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b MAYO CLINIC   (United States)

Author keywords

Anti Vascular Endothelial Growth Factor; Diabetic Retinopathy; Vitrectomy

Indexed keywords

BEVACIZUMAB; SILICONE OIL; TRANEXAMIC ACID; TRIAMCINOLONE; VASCULAR TARGETING AGENT; VASCULOTROPIN;

DIABETIC RETINOPATHY; ENDOTAMPONADE; GAS; HUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK REDUCTION; TREATMENT OUTCOME; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 84856368462     PISSN: 09749233     EISSN: 09751599     Source Type: Journal    
DOI: 10.4103/0974-9233.92120     Document Type: Review

References (18)

1. Smith JM, Steel DH. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. Cochrane Database Syst Rev 2011:CD008214.
2. Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, et al. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am J Ophthalmol 2000;129:178-85. (Pubitemid 30089277)
3. Ho T, Smiddy WE, Flynn HW Jr. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol 1992;37:190-202.
4. Virata SR, Kylstra JA. Postoperative complications following vitrectomy for proliferative diabetic retinopathy with sewon and noncontact wide-angle viewing lenses. Ophthalmic Surg Lasers 2001;32:193-7.
5. West JF, Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 2000;84:822-5. (Pubitemid 30599084)
6. Steel DH, Habib MS, Park S, Hildreth AJ, Owen RI. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography. Ophthalmology 2008;115:525-32.
7. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology 1989;96:1495-500. (Pubitemid 19250960)
8. Blankenship GW. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology 1986;93:39-44. (Pubitemid 16132687)
9. Yeh PT, Yang CM, Yang CH, Huang JS. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: An ultrasound biomicroscopy study. Ophthalmology 2005;112:2095-102.
10. Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: A randomized, clinical trial. Retina 2008;28:1241-6.
11. Ramezani AR, Ahmadieh H, Ghaseminejad AK, Yazdani S, Golestan B. Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage: A randomised clinical trial. Br J Ophthalmol 2005;89:1041-4. (Pubitemid 41081421)
12. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Eur J Ophthalmol 2009;19:618-21.
13. Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 2009;116:1943-8.
14. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM. Intravitreal injection of bevacizumab before vitrectomy or proliferative diabetic retinopathy. Eur J Ophthalmol 2009;19:848-52.
15. di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR. Intravitreal bevacizumab for the surgical treatment of severe proliferative retinopathy. Graefe's Arch Clin Exp Ophthalmol 2010;248:785-91.
16. Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 2008;246:837-42.
17. Farahvash MS, Majidi AR, Roohipoor R, Ghassemi F. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage. Retina 2011;31:1254-60.
18. Ahn J, Woo SJ, Chung H, Park KH. The effect of adjunctive bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. Ophthalmology 2011;118:2218-26.